Tumor Suppression by the Fbw7 Ubiquitin Ligase: Mechanisms and Opportunities

被引:296
作者
Davis, Ryan J. [1 ,2 ,3 ]
Welcker, Markus [1 ,2 ]
Clurman, Bruce E. [1 ,2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA
[3] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA
基金
美国国家科学基金会;
关键词
F-BOX PROTEIN; ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL DIFFERENTIATION; FBXW7; BETA-FORM; CYCLIN-E; C-MYC; DEPENDENT DEGRADATION; PROMOTER HYPERMETHYLATION; MULTISITE PHOSPHORYLATION; SUBSTRATE RECOGNITION;
D O I
10.1016/j.ccell.2014.09.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor suppressors with widespread impact on carcinogenesis control broad spectra of oncogenic pathways. Protein degradation is an emerging mechanism by which tumor suppressors regulate a diversity of pathways and is exemplified by the SCFFbw7 ubiquitin ligase. Rapidly accumulating data indicate that SCFFbw7 regulates a network of crucial oncoproteins. Importantly, the FBXW7 gene, which encodes Fbw7, is one of the most frequently mutated genes in human cancers. These studies are yielding important new insights into tumorigenesis and may soon enable therapies targeting the Fbw7 pathway. Here, we focus on the mechanisms and consequences of Fbw7 deregulation in cancers and discuss possible therapeutic approaches.
引用
收藏
页码:455 / 464
页数:10
相关论文
共 101 条
[91]   Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation [J].
Welcker, M ;
Singer, J ;
Loeb, KR ;
Grim, J ;
Bloecher, A ;
Gurien-West, M ;
Clurman, BE ;
Roberts, JM .
MOLECULAR CELL, 2003, 12 (02) :381-392
[92]   FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation [J].
Welcker, Markus ;
Clurman, Bruce E. .
NATURE REVIEWS CANCER, 2008, 8 (02) :83-93
[93]   Fbw7/hCDC4 dimerization regulates its substrate interactions [J].
Welcker, Markus ;
Clurman, Bruce E. .
CELL DIVISION, 2007, 2 (1)
[94]   Fbw7 dimerization determines the specificity and robustness of substrate degradation [J].
Welcker, Markus ;
Larimore, Elizabeth A. ;
Swanger, Jherek ;
Bengoechea-Alonso, Maria T. ;
Grim, Jonathan E. ;
Ericsson, Johan ;
Zheng, Ning ;
Clurman, Bruce E. .
GENES & DEVELOPMENT, 2013, 27 (23) :2531-2536
[95]   Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia [J].
Weng, AP ;
Ferrando, AA ;
Lee, W ;
Morris, JP ;
Silverman, LB ;
Sanchez-Irizarry, C ;
Blacklow, SC ;
Look, AT ;
Aster, JC .
SCIENCE, 2004, 306 (5694) :269-271
[96]   Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 [J].
Wertz, Ingrid E. ;
Kusam, Saritha ;
Lam, Cynthia ;
Okamoto, Toru ;
Sandoval, Wendy ;
Anderson, Daniel J. ;
Helgason, Elizabeth ;
Ernst, James A. ;
Eby, Mike ;
Liu, Jinfeng ;
Belmont, Lisa D. ;
Kaminker, Josh S. ;
O'Rourke, Karen M. ;
Pujara, Kanan ;
Kohli, Pawan Bir ;
Johnson, Adam R. ;
Chiu, Mark L. ;
Lill, Jennie R. ;
Jackson, Peter K. ;
Fairbrother, Wayne J. ;
Seshagiri, Somasekar ;
Ludlam, Mary J. C. ;
Leong, Kevin G. ;
Dueber, Erin C. ;
Maecker, Heather ;
Huang, David C. S. ;
Dixit, Vishva M. .
NATURE, 2011, 471 (7336) :110-114
[97]   Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E [J].
Won, KA ;
Reed, SI .
EMBO JOURNAL, 1996, 15 (16) :4182-4193
[98]   SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation [J].
Wu, GY ;
Lyapina, S ;
Das, I ;
Li, JH ;
Gurney, M ;
Pauley, A ;
Chui, I ;
Deshaies, RJ ;
Kitajewski, J .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (21) :7403-7415
[99]   Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7 [J].
Yada, M ;
Hatakeyama, S ;
Kamura, T ;
Nishiyama, M ;
Tsunematsu, R ;
Imaki, H ;
Ishida, N ;
Okumura, F ;
Nakayama, K ;
Nakayama, KI .
EMBO JOURNAL, 2004, 23 (10) :2116-2125
[100]   Fbw7 isoform interaction contributes to cyclin E proteolysis [J].
Zhang, Wei ;
Koepp, Deanna M. .
MOLECULAR CANCER RESEARCH, 2006, 4 (12) :935-943